The Aurora Funds

The Aurora Funds is a well-established venture capital firm based in Durham, North Carolina, with a significant history in supporting early-stage companies. Founded in 1994, the firm has consistently focused on providing capital and strategic resources to promising ventures within the healthcare and information technology sectors. Their investment philosophy centers on identifying innovative companies with strong management teams and scalable business models, primarily within the Southeastern United States.

Over its nearly three-decade tenure, The Aurora Funds has demonstrated a commitment to fostering growth in the regional innovation ecosystem. The firm typically deploys initial investments ranging from $500,000 to $5 million, aiming to be a lead or co-lead investor in their portfolio companies. They are known for their hands-on approach, leveraging their extensive network and operational expertise to guide startups through critical development phases. This strategic support extends beyond mere capital, encompassing mentorship, recruitment assistance, and strategic planning.

The firm has raised multiple funds, including Aurora Funds VI, which closed with $125 million, and Aurora Funds VII, which secured $100 million. Their robust portfolio includes over 100 investments, many of which have achieved successful exits through acquisitions or initial public offerings. Notable successes include companies like SciQuest, which went public, and Inspire Pharmaceuticals, which was acquired by Merck. These exits underscore The Aurora Funds' ability to identify and nurture companies that deliver significant returns and contribute to economic development in the region. Their enduring presence and consistent investment activity solidify their role as a cornerstone of the venture capital landscape in the Southeast.